ArticleNeurology and therapy2025

Safety Monitoring of Omaveloxolone in Friedreich Ataxia: Results from One Year of Clinical Treatment.

Katherine Gunther et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.